NanoView Biosciences and Quantum Design China, a subsidiary of Quantum Design International, today announced an exclusive distribution agreement for NanoView’s ExoView® platform in China. “We are...
Read More »NanoView Biosciences and Alfatest Enter into Distribution Agreement
NanoView Biosciences, Inc., and Alfatest today announced an exclusive distribution agreement for NanoView’s ExoView™ platform in Italy.“We believe that scientists in Italy will be excited to have...
Read More »NanoView Biosciences and Quantum Design Japan Enter Into Japanese Distribution Agreement
NanoView Biosciences, Inc., and Quantum Design Japan, a subsidiary of Quantum Design International, today announced an exclusive distribution agreement for NanoView’s ExoView™ platform in Japan. “We are pleased to offer customers in Japan access to the ExoView platform, which allows ...
Read More »NanoView Completes $10 Million Series B Financing
NanoView Biosciences, an emerging leader in the field of exosome detection and characterization, today announced the closing of a $10 million Series B financing led by Northpond Ventures. Existing...
Read More »NanoView Awarded Phase II SBIR grant to support development of innovative exosome characterization platform
NanoView Biosciences, an emerging leader in the field of exosome characterization, has been awarded a National Science Foundation Small Business Innovation Research Phase II grant in the amount of...
Read More »Featured Exosome Job – Field Application Scientist
Location: Boston MA NanoView Biosciences (NanoView) is a startup company developing technologies for the detection and characterization of biofluid based nanoparticles, i.e. extracellular vesicles (EVs) and exosomes. These EVs are being studied for diagnostic and therapeutic applications in high-impact areas ...
Read More »